|
Market Closed -
NYSE
23:30:00 02/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 10.62 USD | -3.28% |
|
-5.01% | -28.00% |
| 09-01 | Daxor Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-30 | Daxor Launches Blood Testing Lab in Eastern Kansis | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Closed End Funds
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 15.13B | - | - | - | - | - |
| 11.89B | - | - | - | - | - |
| 8.48B | - | - | - | - | - |
| 7.27B | - | - | - | - | - |
| 6.86B | - | - | - | - | - |
Select your edition
All financial news and data tailored to specific country editions
